Document:

exv10w64

 

EXHIBIT 10.64

AMENDMENT TO EMPLOYMENT AGREEMENT

     This Amendment to Employment Agreement (the “Amendment”) is entered into effective as
of July 16, 2007 (the “Effective Date”), by and between Jean-Loup Romet-Lemonne (the
“Executive”) and IDM Pharma, Inc., a Delaware corporation (the “Company”).

Recitals

     A. The Company and the Executive have executed that certain Employment Agreement dated as of
April 21, 2005 (the “Original Agreement”).

     B. In consideration of the premises, and other good and valuable consideration, receipt of
which is hereby acknowledged by the parties, the Company and the Executive desire to amend the
Original Agreement and provide for Executive’s resignation from the Company’s Board of Directors as
specified herein, in each case effective as of the Effective Date.

Agreement

     The Company and the Executive, intending to be legally bound, agree as follows effective as of
the Effective Date:

1. Amendment of Original Agreement.

          (a) Deletion of Sections 2.2 and 2.3. Sections 2.2 and 2.3 of the Original Agreement are
hereby deleted in their entirety.

          (b) Amendment of Section 4.4.4. The first paragraph of Section 4.4.4 of the Original
Agreement is hereby amended to read as follows:

     “4.4.4 With Good Reason. If the Executive resigns with Good Reason,
then the Company shall pay the Executive’s Base Salary and accrued and
unused vacation earned through the date of termination, at the rate in
effect at the time of termination subject to standard deductions and
withholdings. In addition, subject to the limitations stated in Section
4.4.6 herein and upon the Executive’s furnishing to the Company, an
effective waiver and release of claims (a form of which is attached hereto
as Exhibit A), within the time period set forth therein, but in no event
later than forty-five (45) days following termination (the “Release”), and
such Release becoming effective in accordance with its terms, the Executive
shall be entitled to:”

          (c) Amendment of Section 4.4.5. The first paragraph of Section 4.4.5 of the Original
Agreement is hereby amended to read as follows:

     “4.4.5 Without Cause. If the Company terminates the Executive’s
employment without Cause, the Company shall pay the Executive’s Base Salary
and accrued and unused vacation earned through

 

 

the date of termination, at the rate in effect at the time of
termination subject to standard deductions and withholdings. In addition,
subject to the limitations stated in Section 4.4.6 herein and upon the
Executive’s furnishing to the Company the Release within the time period set
forth therein, but in no event later than forty-five (45) days following
termination, and such Release becoming effective in accordance with its
terms, the Executive shall be entitled to:”

          (d) Amendment of Section 4.4.5(i). Section 4.4.5(i) of the Original Agreement is hereby
amended to read in its entirety as follows:

     “(i) continuation of the Executive’s annual Base Salary in effect at
the time of termination for a period beginning upon the Effective Date of
the Release and continuing for twenty four (24) months thereafter (the
“Without Cause Severance Period”), less standard deductions and
withholdings, paid pursuant to the Company’s standard payroll practices;
and”

          (e) Amendment of Section 4.5.2. Section 4.5.2 of the Original Agreement is hereby amended to
read in its entirety as follows:

     “4.5.2 Good Reason. For purposes of this Agreement, Executive shall have
“Good Reason” for Executive’s resignation if: (w) any of the following occurs
without Executive’s consent; (x) Executive notifies the Company in writing that
Executive intends to terminate his employment no earlier than thirty (30) days after
providing the notice required by Section 4.2.1 of this Agreement; (y) the Company
does not cure such condition within thirty (30) days following its receipt of such
notice or states unequivocally in writing that it does not intend to attempt to cure
such condition, and (z) the Executive resigns from employment within thirty (30)
days following the end of the period within which the Company was entitled to remedy
the condition constituting Good Reason but failed to do so:

     (i) without the Executive’s consent, a material reduction in the Executive’s
duties, authority, or responsibilities relative to the duties, authority, or
responsibilities in effect immediately prior to such reduction;

     (ii) without the Executive’s consent, the relocation of the Executive’s
principal place of business to a point that is not within thirty five (35) miles of
either 5820 Nancy Ridge Drive, San Diego, California, or 9 Parker, Irvine,
California;

     (iii) a material reduction by the Company of the Executive’s base salary as
initially set forth herein or as the same may be increased from time to time,
provided that if such reduction occurs in connection with a Company wide decrease in
Executive salaries and the percent decrease in the Executive’s base salary does not
exceed the percent decrease in base salary of any other executive

 

 

of the Company such reduction will not constitute Good Reason to
terminate Executive’s employment for purposes of this Agreement; or

     (iv) a material breach by the Company of Section 6 of this Agreement.”

          (f) Amendment of Section 6: The following provision is added to the end of Section 6 of the
Original Agreement:

     “The Company shall obtain the assumption of this Agreement by any successor
or assign of the Company. which shall agree to assume the obligations and perform
all of the terms and conditions of this Agreement.”

          (g) New Section 19: A new Section 19 is hereby added to the Original Agreement as follows:

     “19. Deferred Compensation. Severance benefits payable pursuant to this
Agreement, to the extent of payments made from the date of termination of
Executive’s employment through March 15th of the calendar year following such
termination, are intended to constitute separate payments for purposes of Section
1.409A-2(b)(2) of the Treasury Regulations and thus payable pursuant to the
“short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury
Regulations; to the extent such payments are made following said March 15th, they
are intended to constitute separate payments for purposes of Section 1.409A-2(b)(2)
of the Treasury Regulations made upon an involuntary termination from service and
payable pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations, to the
maximum extent permitted by said provision, with any excess amount being regarded as
subject to the distribution requirements of Section 409A(a)(2)(A) of the Code,
including, without limitation, the requirement of Section 409A(a)(2)(B)(i) of the
Code that payment to Executive be delayed until 6 months after Executive’s
separation from service if Executive is a “specified employee” within the meaning of
the aforesaid section of the Code at the time of such separation from service.”

     2. Board Resignation and Removal.

          (a) Resignation. By executing this Amendment, Executive hereby resigns from the Company’s
Board of Directors as of the Effective Date

          (b) Removal from Board. As of the Effective Date the Executive shall be automatically removed
from the Board without the necessity of any formal action by the Board.

     3. Miscellaneous Provisions.

          (a) Original Agreement. The Original Agreement, as amended by this Amendment, shall continue
in full force and effect after the date hereof. This Amendment shall not affect the Executive’s
execution of that certain Waiver and Release signed on June 5, 2007
(the “Release”), which shall remain in full force and effect, nor the Executive’s entitlement to

 

 

benefits pursuant to Section 4.4.5 the Original Agreement (as modified by section 1(d) of this
Amendment) based on the execution of the Release.

          (b) Whole Agreement. No agreements, representations or understandings (whether oral or
written and whether express or implied) which are not expressly set forth in the Original
Agreement, as amended by this Amendment, have been made or entered into by either party with
respect to the subject matter of this Amendment.

[Remainder of this page intentionally left blank]

 

 

     In Witness Whereof, each of the parties has executed this Amendment, in the case of
the Company by its duly authorized officer, effective as of the day and year first above written.

	 	 	 	 	 	 	 
	 	 	“Company”	 	 
	 
	 	 	 	 	 	 
	 	 	IDM Pharma, Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Sylvie Grégoire	 	 
	 

	 	 	 	 

     [Name]
	 	 
	 
	 	 	 	 	 	 
	 

	 	 	 	     Title:    Chairman of the Board	 	 
	 
	 	 	 	 	 	 
	 	 	“Executive”	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Jean-Loup Romet-Lemonne	 	 
	 	 	 	 	 
	 	 	Jean-Loup Romet-Lemonneexv10w34

 

Exhibit 10.34

SEVERANCE PROTECTION AGREEMENT

     This Severance Protection Agreement (this “Agreement”) is entered into effective as of August
7, 2007, between Diane S. Goostree (“Employee”) and Artes Medical, Inc., a Delaware corporation
(the “Company”).

RECITALS

     A. The Board of Directors (the “Board”) believes it is in the best interests of the Company
and its stockholders to provide incentives to Employee to continue in the service of the Company
and aid in any future Change of Control (as defined below) event.

     B. The Company and Employee are parties to an Employment Offer Letter dated February 13, 2006
(the “Existing Agreement”).

     C. Employee has been granted stock options issued under the Company’s 2001 Stock Option Plan
(the “2001 Plan”) and the 2006 Equity Incentive Plan (the “2006 Plan”) as set forth on Schedule
A attached hereto (collectively, the “Options”).

AGREEMENT

     Now therefore, in consideration of the mutual promises, covenants and agreements contained
herein, and in consideration of the continuing employment of Employee by the Company, the parties
hereto agree as follows:

ARTICLE I

CHANGE OF CONTROL AND INVOLUNTARY TERMINATION

     1.1 Accelerated Vesting of Options. Notwithstanding anything to the contrary in the Existing
Agreement, the Options or the 2001 and 2006 Plans,

          (a) one hundred percent (100%) of the then unvested shares (including any option shares that did
not vest based on the Company’s performance during a fiscal
year) covered by the Option granted on
February 2, 2007, and fifty percent (50%) of the then unvested
shares covered by any of the other
Options shall automatically vest upon the closing date of a Change of Control (as defined below) if
(i) Employee provides services to the Company as an employee or a consultant continuously through
the closing date of such Change of Control or (ii) Employee’s employment with the Company ends by
reason of an Involuntary Termination (as defined below) within three (3) months prior to the
closing date of such Change of Control; and

          (b) any remaining unvested shares under the Options shall automatically vest upon Employee’s
termination should Employee’s employment be terminated by reason of an Involuntary Termination on
or within twenty-four (24) months following the closing date of such Change of Control.

 

 

     1.2 Involuntary Termination Severance. Should Employee’s employment with the Company or the
Surviving Company (as defined below) be terminated by reason of an Involuntary Termination within
three (3) months prior to the closing date of a Change of Control or within twenty-four (24) months
following the closing date of such Change of Control and contingent upon the Employee’s execution
of the Release (attached hereto as Attachment A) and the Release becoming effective under
its terms, the Company shall

          (a) pay Employee severance (“Involuntary Termination Severance”) equal to: (i) nine (9) months
of Employee’s Base Salary (as defined below) plus (ii) any earned, but not yet paid, pending bonus
from a completed calendar year which shall be calculated based upon the target bonus percentage in
the Existing Agreement plus (iii) the product of (A) the average amount of the bonus, if any,
Employee received from the Company in connection with Employee’s services to the Company during the
last three fiscal years prior to the effective date of the Involuntary Termination and (B) the
number of days between the last day of the fiscal year preceding the Involuntary Termination and
the effective date of the Involuntary Termination divided by 365 days. The Company shall pay the
Involuntary Termination Severance to Employee in one lump sum within fifteen (15) days of the
effective date of the Release executed in connection with the Involuntary Termination, and shall
deduct from the Involuntary Termination Severance all applicable payroll deductions and all
required withholdings; and

          (b) provided Employee timely makes an election to continue coverage under the Company’s or the
Surviving Company’s group health plan pursuant to the Consolidated Omnibus Budget Reconciliation
Act of 1985 (“COBRA”), the Company or the Surviving Company will pay Employee’s COBRA premiums for
a maximum period of nine (9) months following the effective date of the Release executed in
connection with Employee’s Involuntary Termination (the “Change of Control COBRA Continuation
Period”). In addition, if Employee’s spouse and/or dependents were enrolled in the Company’s or
the Surviving Company’s group health plan on the effective date of Employee’s Involuntary
Termination, the Company will pay the COBRA premiums for Employee’s eligible dependents during the
same nine (9) month period, but only to the same extent that such dependents’ premiums under such
plan were paid by the Company or the Surviving Company prior to the effective date of Employee’s
Involuntary Termination. No provision of this Agreement will affect the continuation coverage
rules under COBRA, except that the Company’s or the Surviving Company’s payment of any applicable
premiums during the Change of Control COBRA Continuation Period will be credited as payment by
Employee for purposes of the Employee’s payment required under COBRA. At the conclusion of the
Change of Control COBRA Continuation Period, Employee will be responsible for the entire payment of
premiums required under COBRA for the remaining duration of eligibility for COBRA, if any. Nothing
in this Section 1.2(b) shall restrict the ability of the Company or its successor from changing the
provider and/or some or all of the terms of such health insurance plan, provided that all similarly
situated participants are treated the same and provided, further, that Employee and Employee’s
eligible dependents receive approximately the same benefits they were eligible to receive prior to
the change in provider and/or some or all of the terms of such health insurance plan.

Page 2 of 12

 

ARTICLE 2

RESIGNATION
FOR GOOD REASON AND TERMINATION FOR OTHER THAN CAUSE

     2.1 In the absence of a Change of Control, or more than 24 months after a Change of Control,
should Employee at any time be terminated for other than Cause, or elect a Good Reason Resignation
(as defined herein), Employee shall be entitled to the following:

          (a) Accelerated Vesting of Options. Notwithstanding anything to the contrary in the 2001 or
2006 Plans, Employee’s then unvested option shares (including any option shares that did
not vest based on the Company’s performance during a fiscal
year) will receive accelerated vesting treatment in
an amount such that the shares that would have vested over the next nine (9) months had such
resignation or termination not occurred shall be immediately vested upon the Employee’s termination
or resignation.

          (b) Base Salary and Bonus. Contingent upon the Employee’s execution of the Release and the
Release becoming effective under its terms, the Company shall pay Employee severance equal to: (i)
nine (9) months of Employee’s Base Salary (as defined below) plus (ii) any earned, but not yet
paid, pending bonus from a completed calendar year which shall be calculated based upon the target
bonus percentage in the Existing Agreement plus (iii) the product of (A) the average amount of the
bonus, if any, Employee received from the Company in connection with Employee’s services to the
Company during the last three fiscal years prior to the effective date of the termination or
resignation and (B) the number of days between the last day of the fiscal year preceding the
termination or resignation and the effective date of the termination or resignation divided by 365
days. The Company shall pay the severance set forth in this Section 2.1(b) to Employee in one lump
sum within fifteen (15) days of the effective date of the Release executed in connection with the
termination without Cause or Good Reason Resignation, and shall deduct from the severance all
applicable payroll deductions and all required withholdings.

          (c) COBRA Premiums. Provided Employee timely makes an election to continue coverage under the
Company’s or the Surviving Company’s group health plan pursuant to COBRA, the Company or the
Surviving Company will pay Employee’s COBRA premiums for a maximum period of nine (9) months
following the effective date of the Release executed in connection with Employee’s termination
without Cause or Good Reason Resignation (the “COBRA Continuation Period”). In addition, if
Employee’s spouse and/or dependents were enrolled in the Company’s or the Surviving Company’s group
health plan on the effective date of Employee’s termination without Cause or Good Reason
Resignation, the Company will pay the COBRA premiums for Employee’s eligible dependents during the
same nine (9) month period, but only to the same extent that such dependents’ premiums under such
plan were paid by the Company or the Surviving Company prior to the effective date of Employee’s
termination without Cause or Good Reason Resignation. No provision of this Agreement will affect
the continuation coverage rules under COBRA, except that the Company’s or the Surviving Company’s
payment of any applicable premiums during the COBRA Continuation Period will be credited as payment
by Employee for purposes of the Employee’s payment required under COBRA. At the conclusion of the
COBRA Continuation Period, Employee will be responsible

Page 3 of 12

 

for the entire payment of premiums required under COBRA for the remaining duration of
eligibility for COBRA, if any. Nothing in this Section 2.1(c) shall restrict the ability of the
Company or its successor from changing the provider and/or some or all of the terms of such health
insurance plan, provided that all similarly situated participants are treated the same and
provided, further, that Employee and Employee’s eligible dependents receive approximately the same
benefits they were eligible to receive prior to the change in provider and/or some or all of the
terms of such health insurance plan.

ARTICLE 3

DEFINITIONS

     For purposes of this Agreement, the following terms are defined as follows:

     3.1 “Base Salary” means the Employee’s base salary (exclusive of bonuses, awards under the
Company’s 2001 and 2006 Plans and other forms of supplemental or equity–based compensation) at the
rate in effect during the last regularly scheduled payroll period immediately preceding the date of
the event in question, computed before any deferrals or pre-tax or post-tax payroll deductions.

     3.2 “Cause” shall mean the occurrence of any one or more of the following: (a) Employee’s
conviction of, or plea of no contest with respect to, any felony involving fraud or dishonesty; (b)
Employee’s participation in a fraud or act of dishonesty against the Company that results in
material harm to the business of the Company; (c) Employee’s material breach of any contract or
agreement or direct order between Employee and the Company or any statutory duty Employee owes to
the Company; (d) Employee’s willful failure or refusal to comply with a lawful instruction of the
Board; or (e) Employee’s habitual neglect of duties or incompetence that results in material harm
to the business of the Company; provided, however, that with respect to a termination based on
clauses (c) and/or (e) above, the action or conduct continues after the Company has provided
Employee with written notice thereof and 15 days to cure the same.

     3.3 “Change of Control” means (a) a merger or consolidation in which the Company is not the
surviving corporation (other than a merger or consolidation with a wholly-owned subsidiary, a
reincorporation of the Company in a different jurisdiction, or other transaction in which there is
no substantial change in the stockholders of the Company or their relative stock holdings), (b) a
merger in which the Company is the surviving corporation but after which the stockholders of the
Company immediately prior to such merger (other than any stockholder that merges, or which owns or
controls another corporation that merges, with the Company in such merger) cease to own their
shares or other equity interest in the Company, (c) the sale of all or substantially all of the
assets of the Company, or (d) the acquisition, sale, or transfer of more than 50% of the
outstanding shares of the Company by tender offer or similar transaction.

     3.4 “Disabled” means disability as defined in Section 22(e) of the Internal Revenue Code of
1986, as amended.

     3.5 “Involuntary Termination” means within three (3) months prior to or within twenty-four
(24) months following a Change of Control: (a) the Company or the Surviving

Page 4 of 12

 

Company terminate Employee’s employment without Cause by the Company or the Surviving Company
or (b) Employee resigns from the Company or the Surviving Company within sixty (60) days following:
(i) a reduction in Employee’s level of compensation (including Base Salary and fringe benefits) by
more than twenty percent (20%) in the aggregate (other than in connection with a general decrease
in the salary applicable to all executives of the Company or all executives of the Surviving
Company), (ii) a relocation by the Company or the Surviving Company of Employee’s work site to a
facility or location more than fifty (50) miles from Employee’s principal work site for the Company
at the time of the Change of Control, or (iii) a material reduction in Employee’s duties or
responsibilities without Employee’s consent.

     3.6 “Good Reason Resignation” means Employee’s resignation of employment with the Company or
any Surviving Company in the absence of a Change of Control within sixty (60) days following: (i) a
reduction in Employee’s level of compensation (including Base Salary and fringe benefits) by more
than twenty percent (20%) in the aggregate (other than in connection with a general decrease in the
salary applicable to all executives of the Company or all executives of any Surviving Company),
(ii) a relocation by the Company or any Surviving Company of Employee’s work site to a facility or
location more than fifty (50) miles from Employee’s principal work site for the Company at the time
of the Good Reason Resignation , or (iii) a material reduction in Employee’s duties or
responsibilities without Employee’s consent.

     3.7 “Options,” as defined above, shall also include each and all future stock option grants,
if any, issued by the Company to Employee pursuant to the 2006 Plan, and Schedule A
attached hereto shall be automatically amended, without further action by the Employee or the
Company, on the date of the issuance of each such additional Option(s) to include such Option(s) on
Schedule A, unless the terms of the Option(s) expressly state(s) that such Option(s) shall
not be subject to the terms and conditions of this Agreement. The Company will promptly furnish to
Employee a copy of the amendment(s) to Schedule A, if any, referred to in the preceding
sentence.

     3.8 “Surviving Company” means any company into which the Company is merged or consolidated in
connection with a Change of Control.

ARTICLE 4

GENERAL PROVISIONS

     4.1 Employment Status. This Agreement does not constitute a contract of employment or impose
on Employee any obligation to remain as an employee, or impose on the Company any obligation (a) to
retain Employee as an employee, (b) to change the status of Employee as an at-will employee, (c) to
change the Company’s policies regarding termination of employment; or (d) to be unable to terminate
Employee’s employment with the Company at any time, with or without notice, for any reason or no
reason.

     4.2 Covenants of Employee. Employee agrees that Employee will provide reasonable assistance
with respect to the negotiation and consummation of any Change of Control, including all due
diligence procedures undertaken in connection therewith or the winding-up of the Company’s affairs.

Page 5 of 12

 

     4.3 Termination. The terms of this Agreement shall terminate upon the earlier of (a) the date
of Employee’s voluntary termination of employment with the Company or any Surviving Company for any
reason other than an Involuntary Termination or a Good Reason Resignation, (b) the date of
termination of Employee’s employment with the Company or any Surviving Company for Cause, (c) the
date of termination of Employee’s employment with the Company or any Surviving Company because
Employee dies or becomes Disabled, and (d) the date that all obligations of the parties hereunder
have been satisfied.

     4.4 Notices. Any notices provided hereunder must be in writing and such notices or any other
written communication shall be deemed effective upon the earlier of personal delivery (including
delivery by facsimile) or the third day after mailing by first class mail, to the Company at its
primary office location and to Employee at Employee’s address as listed in the Company’s payroll
records. Any payments made by the Company to Employee under the terms of this Agreement shall be
delivered to Employee either in person or at the address as listed in the Company’s payroll
records.

     4.5 Severability. If a legal authority of competent jurisdiction determines that any term or
provision of this Agreement is invalid or unenforceable, in whole or in part, then the remaining
terms and provisions hereof shall be unimpaired. Such legal authority will have the authority to
modify or replace the invalid or unenforceable term or provision with a valid and enforceable term
or provision that most accurately embodies the parties’ intention with respect to the invalid or
unenforceable term or provision.

     4.6 Complete Agreement. This Agreement, including Attachment A and any other written
agreements referred to in this Agreement, constitutes the entire agreement between Employee and the
Company with regard to the subject matter hereof, and supersedes and replaces any contrary terms of
the Existing Agreement, which contrary terms of the Existing Agreement shall have no further force
or effect. Notwithstanding the foregoing, the First Amended Offer of Employment dated November 27,
2006 shall remain in full force and effect and is not superseded by this Agreement.

     4.7 Amendment or Termination of Agreement. This Agreement may be changed or terminated only
upon the mutual written consent of the Company and Employee. The written consent of the Company to
a change or termination of this Agreement must be signed by an officer of the Company after such
change or termination has been approved by the Board.

     4.8 Counterparts. This Agreement may be executed in separate counterparts, any one of which
need not contain signatures of more than one party, but all of which taken together will constitute
one and the same Agreement.

     4.9 Successors and Assigns. This Agreement is intended to bind and inure to the benefit of
and be enforceable by Employee and the Company, and their respective successors, assigns, heirs,
executors and administrators, except that Employee may not assign any duties hereunder and may not
assign any rights hereunder without the prior written consent of the Company. If a Change in
Control of the Company occurs and the Company does not survive the transaction as an entity, the
Company will require the Surviving Company to assume the Company’s obligations hereunder.

Page 6 of 12

 

     4.10 Attorneys’ Fees. If either party hereto brings any action to enforce his, her or its
rights hereunder, the prevailing party in any such action shall be entitled to recover his, her or
its reasonable attorneys’ fees and costs incurred in connection with such action.

     4.11 Advice of Counsel. Employee represents and warrants that Employee has had the
opportunity to (and was encouraged to) obtain the advice of independent counsel with respect to the
review, preparation and execution of this Agreement. Employee further acknowledges that Heller
Ehrman LLP represented solely the interests of the Company with respect to preparation of this
Agreement.

     4.12 Choice of Law. All questions concerning the construction, validity and interpretation of
this Agreement will be governed by the laws of the State of California, without regard to such
state’s conflict of laws rules.

Page 7 of 12

 

     IN WITNESS WHEREOF, the parties have executed this Agreement on the day and year written above.

	 	 	 	 	 	 	 
	 	 	ARTES MEDICAL, INC.
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Christopher J. Reinhard	 	 
	 

	 	 	 	 

	 	 
	 

	 	Name:	 	Christopher J. Reinhard	 	 
	 

	 	 	 	 

	 	 
	 

	 	Title:	 	Executive Chairman of the Board	 	 
	 

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 
	 	 	EMPLOYEE
	 
	 	 	 	 	 	 
	 	 	/s/ Diane S. Goostree
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Diane S. Goostree

Page 8 of 12

 

SCHEDULE A

OPTION SUMMARY

 

	 	 	 	 	 	 	 
	 	Grant	 	Options	 	Price per	 
	 	Date	 	Granted	 	Option	 
	 	03/24/2006	 	117,647	 	$5.31	 
	 	06/30/2006	 	47,058	 	$7.86	 
	 	02/02/2007	 	300,000	 	$9.96	 

Page 9 of 12

 

ATTACHMENT A

GENERAL RELEASE AND

COVENANT NOT TO SUE

     Certain capitalized terms used in this Release are defined in the Severance Protection
Agreement (the “Agreement”) which each party hereto has executed and of which this General Release
and Covenant Not to Sue (the “Release”) is a part.

     Employee, on his or her own behalf and on behalf of his or her descendants, dependents, heirs,
executors and administrators and permitted assigns, past and present, in consideration for the
Company’s performance of its obligations under the Agreement, does hereby covenant not to sue or
pursue any litigation (or file any charge or otherwise correspond with any Federal, state or local
administrative agency) against, and waives, releases and discharges the Company, and its respective
assigns, affiliates, subsidiaries, parents, predecessors and successors, and the past and present
stockholders, employees, officers, directors, representatives and agents or any of them
(collectively, the “Company Group”), from any and all claims, demands, rights, judgments, defenses,
actions, charges or causes of action whatsoever (collectively, “Claims”), of any and every kind and
description, whether known or unknown, accrued or not accrued, that Employee ever had, now has or
shall or may have or assert as of the date of this Release against any of them, including, without
limiting the generality of the foregoing, any Claims related to employment or termination of
employment or that arise out of or relate in any way to the Age Discrimination in Employment Act of
1967 (“ADEA”), as amended, the Older Workers Benefit Protection Act, Title VII of the Civil Rights
Act of 1964, as amended, and other Federal, state and local laws relating to discrimination on the
basis of age, sex or other protected class, all claims under Federal, state or local laws for
express or implied breach of contract, wrongful discharge, defamation, intentional infliction of
emotional distress, and any related claims for attorneys’ fees and costs; provided,
however, that nothing herein shall release any member of the Company Group from (i) any of
its obligations under the Agreement or (ii) any rights of the Employee to indemnification by any
member of the Company Group pursuant to the Company’s charter, bylaws or insurance policies or any
applicable statutes (including, but not limited to, California Labor Code 2802) as a result of his
or her service as an officer or director of the Company. The Employee further agrees that this
Release may be pleaded as a full defense to any action, suit or other proceeding covered by the
terms hereof which is or may be initiated, prosecuted or maintained by the Employee, his or her
heirs or assigns. Notwithstanding the foregoing, the Employee understands and confirms that he or
she is executing this Release voluntarily and knowingly, and this Release shall not affect the
Employee’s right to claim otherwise under ADEA. In addition, the Employee shall not be precluded
by this Release from filing a charge with any relevant Federal, State or local administrative
agency, but the Employee agrees not to participate in, and agrees to waive his rights with respect
to any monetary or other financial relief arising from any such administrative proceeding.

     The Company, on its own behalf and on behalf of its assigns, affiliates, subsidiaries,
parents, predecessors and successors, and its past and present shareholders, employees, officers,
directors, representatives and agents or any of them, does hereby covenant not to sue or pursue any
litigation (or file any charge or otherwise correspond with any Federal, state or local

Page 10 of 12

 

administrative agency) against, and waives, releases and discharges Employee and his or her
heirs, successors and assigns, descendants, dependents, executors and administrators, past and
present, and any of his or her affiliates and each of them (collectively, the “Employee
Group”) from any and all Claims, of any and every kind and description, whether known or
unknown, accrued or not accrued, that the Company or any of its subsidiaries ever had, now has or
shall or may have or assert as of the date of this Release against any of them, based on facts
known to any executive officer of the Company as of the date of this Release (other than the
Employee), including specifically, but not exclusively and without limiting the generality of the
foregoing, any and all claims, demands, agreements, obligations and causes of action arising out of
or in any way connected with any transaction, occurrence, act or omission related to Employee’s
employment by the Company or any of its subsidiaries or the termination of that employment;
provided, however, that nothing herein shall release the Employee Group from any
obligations arising out of or related in any way to Employee’s obligations under the Agreement, any
agreement governing the terms of any stock options granted to the Employee or impair the right or
ability of the Company to enforce the terms thereof and any proprietary information and inventions
agreement between the Company and Employee.

     In furtherance of their respective agreements set forth above, each of the Employee and the
Company hereby expressly waives and relinquishes any and all rights under any applicable statute,
doctrine or principle of law restricting the right of any person to release claims which such
person does not know or suspect to exist at the time of executing a release, which claims, if
known, may have materially affected such person’s decision to give such a release. In connection
with such waiver and relinquishment, each of the Employee and the Company acknowledges that it is
aware that it may hereafter discover claims presently unknown or unsuspected, or facts in addition
to or different from those which it now knows or believes to be true, with respect to the matters
released herein. Nevertheless, it is the intention of each of the Employee and the Company to
fully, finally and forever release all such matters, and all claims relative thereto which now
exist, may exist or theretofore have existed, as specifically provided herein. The parties hereto
acknowledge and agree that this waiver shall be an essential and material term of the release
contained above. In addition, and not by way of limitation to the foregoing, each of the Employee
and the Company fully understands and knowingly and expressly waives its rights and benefits under
Section 1542 of the California Civil Code or under any similar provision of law. Section 1542 of
the California Civil Code states that:

“A general release does not extend to claims which the creditor does not know or
suspect to exist in his or her favor at the time of executing the release, which if
known by him or her must have materially affected his or her settlement with the
debtor.”

Nothing in this paragraph is intended to expand the scope of the release as specified herein.

     This Release shall be governed by and construed in accordance with the laws of the State of
California, applicable to agreements made and to be performed entirely within such State.

     To the extent that the Employee is forty (40) years of age or older, this paragraph shall
apply. The Employee acknowledges that he or she has been offered a period of time of at least
twenty-one (21) days to consider whether to sign this Release, and the Company agrees that the

Page 11 of 12

 

Employee may cancel this Release at any time during the seven (7) days following the date on
which this Release has been signed by all parties to this Release. In order to cancel or revoke
this Release, the Employee must deliver to the General Counsel of the Company written notice
stating that the Employee is canceling or revoking this Release. If this Release is timely
cancelled or revoked, none of the provisions of this Release shall be effective or enforceable and
the Company shall not be obligated to make the payments to the Employee or to provide the Employee
with the other benefits described in the Agreement and all contracts and provisions modified,
relinquished or rescinded hereunder shall be reinstated to the extent in effect immediately prior
hereto.

     Each of the Employee and the Company acknowledge that they have entered into this Release
knowingly and willingly and has had ample opportunity to consider the terms and provisions of this
Release.

	 	 	 	 	 	 	 
	 	 	ARTES MEDICAL, INC.
	 
	 	 	 	 	 	 
	 

	 	By:	 	/s/ Christopher J. Reinhard	 	 
	 

	 	 	 	 

	 	 
	 

	 	Name:	 	Christopher J. Reinhard	 	 
	 

	 	 	 	 

	 	 
	 

	 	Title:	 	Executive Chairman of the Board	 	 
	 

	 	 	 	 

	 	 
	 
	 	 	 	 	 	 
	 	 	EMPLOYEE
	 
	 	 	 	 	 	 
	 
	 	 	/s/ Diane S. Goostree
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Diane S. Goostree
	 
	 	 	 	 	 	 
	 
	 

	 	Date:	 	August 7, 2007	 	 
	 

	 	 	 	 

	 	 

Page 12 of 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]